BAFL 53.19 Increased By ▲ 3.16 (6.32%)
BIPL 22.90 Increased By ▲ 0.49 (2.19%)
BOP 5.67 Increased By ▲ 0.25 (4.61%)
CNERGY 5.12 Increased By ▲ 0.07 (1.39%)
DFML 19.35 Increased By ▲ 0.17 (0.89%)
DGKC 80.54 Increased By ▲ 0.39 (0.49%)
FABL 33.11 Increased By ▲ 0.26 (0.79%)
FCCL 20.25 No Change ▼ 0.00 (0%)
FFL 10.48 Increased By ▲ 0.83 (8.6%)
GGL 13.61 Increased By ▲ 0.01 (0.07%)
HBL 129.52 Increased By ▲ 8.18 (6.74%)
HUBC 123.38 Increased By ▲ 0.88 (0.72%)
HUMNL 8.04 Increased By ▲ 0.04 (0.5%)
KEL 4.43 Increased By ▲ 0.46 (11.59%)
LOTCHEM 28.01 Decreased By ▼ -0.07 (-0.25%)
MLCF 42.71 Increased By ▲ 0.51 (1.21%)
OGDC 125.38 Increased By ▲ 4.05 (3.34%)
PAEL 21.33 Increased By ▲ 1.10 (5.44%)
PIBTL 6.11 Increased By ▲ 0.31 (5.34%)
PIOC 118.47 Increased By ▲ 2.57 (2.22%)
PPL 113.85 Increased By ▲ 3.10 (2.8%)
PRL 31.80 Increased By ▲ 2.22 (7.51%)
SILK 1.10 Increased By ▲ 0.02 (1.85%)
SNGP 69.44 Increased By ▲ 0.41 (0.59%)
SSGC 13.76 Increased By ▲ 0.06 (0.44%)
TELE 9.16 Increased By ▲ 0.41 (4.69%)
TPLP 14.79 Increased By ▲ 0.12 (0.82%)
TRG 92.45 Increased By ▲ 1.15 (1.26%)
UNITY 27.47 Increased By ▲ 0.22 (0.81%)
WTL 1.67 Increased By ▲ 0.04 (2.45%)
BR100 6,815 Increased By 167.1 (2.51%)
BR30 24,245 Increased By 677 (2.87%)
KSE100 66,224 Increased By 1505.6 (2.33%)
KSE30 22,123 Increased By 529.1 (2.45%)
World

Brazil green-lights Pfizer vaccine for kids 12 and up

  • The health regulator, Anvisa, said the approval was based on studies by Pfizer that "indicated the vaccine's safety and effectiveness for this age group."
Published June 11, 2021

SAO PAULO: Brazil's health regulator approved the Pfizer Covid-19 vaccine Friday for use in children aged 12 and up, though they will likely have to wait months in line for older age groups to be vaccinated first.

Hit hard by the pandemic, Brazil joins countries including the United States, Uruguay and Chile in extending vaccination to minors.

However, supply issues mean the move is mainly symbolic for now.

Brazil's Covid-19 vaccination drive, which began in January, has been hit by shortages and delays.

Around 11 percent of the country's 212 million people have been fully vaccinated so far.

Cities such as Sao Paulo and Rio de Janeiro have only recently finished vaccinating priority groups such as health workers and the elderly.

They are now vaccinating the general population in descending order by age, and are currently immunizing people in their 50s.

The health regulator, Anvisa, said the approval was based on studies by Pfizer that "indicated the vaccine's safety and effectiveness for this age group."

In addition to the US pharmaceutical giant's vaccine, developed with German firm BioNTech, Brazil is currently using the Oxford/AstraZeneca vaccine and Chinese-developed CoronaVac.

Regulators have also approved the Johnson & Johnson vaccine, but the government has not yet reached a deal to purchase it.

Brazil has struggled to source enough vaccine doses.

Far-right President Jair Bolsonaro faces criticism for refusing offers of vaccines last year, including from Pfizer, and instead pushing the ineffective medication chloroquine against Covid-19.

The pandemic has claimed more than 480,000 lives in Brazil, second only to the United States.

Comments

Comments are closed.

Brazil green-lights Pfizer vaccine for kids 12 and up

Govt seeks to cure Sino-Pak trade imbalance

Independent directors’ selection: SECP directs cos to exercise due diligence

700.7MW hydel power project: Chinese co urges PPIB to grant extension in financial close

Yemen rebels threaten Israel-bound Red Sea ships

SIFC panel for single authority to manage all SEZs

IMF scheduled to consider first review of $3bn SBA on Jan 11

Gaza war puts entire generation at risk of 'radicalisation': Qatar PM

North Korea condemns US veto of Gaza ceasefire call at UN

Police force needs to improve its image: PM

China, Saudi to expand trade and investment cooperation